A Safety and Tolerability Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus
Clinical trial NCT03162926 · COMPLETED
Trial details
- NCT number
- NCT03162926
- Sponsor
- ViaCyte
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-05
- Primary completion
- 2018-02-15
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.